跳至主要内容
临床试验/CTRI/2024/08/072131
CTRI/2024/08/072131尚未招募2 期

Effectiveness of platelet rich plasma in comparison with Triamcinolone Hexacetonide in improving pain and function in patients with de Quervains tenosynovitis: A Randomised controlled trial

Regional institute of medical sciences1 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2024年8月20日最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
52
试验地点
1
主要终点
Visual analogue scale (VAS)

研究概览

简要总结

This study is a randomised parallel group active controlled trial comparing ultrasound guided platelet rich plasma injection with Triamcinolone hexacetonide in improving pain and function in patients with de quervain tenosynovitis. Among 52 patients that will be conducted in Dept. of PMR RIMS, Imphal. The outcome measures for the study will be Visual analogue scale and Quick DASH measured at baseline and 1,4,12,24 weeks post intervention.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Outcome Assessor Blinded

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Age between 20-60 years of both genders 2.Duration of symptoms less than 6 weeks 3.Visual analogue scale (VAS) ≥ 4 4.Patients willing for study and follow up assessments.

排除标准

  • Patients with uncontrolled diabetes
  • Congenital deformity of hand
  • Rheumatoid arthritis
  • Pregnancy
  • Local infection
  • Thrombocytopenia
  • Impaired cognition.

结局指标

主要结局

Visual analogue scale (VAS)

时间窗: 1,4,12,24 weeks

次要结局

  • Quick DASH(1,4,12,24 weeks)

研究者

申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

WUPPI MIKU

Department of Physical Medicine and Rehabilitation Regional Institute of medical sciences

研究点 (1)

Loading locations...

相似试验